Business Daily Media

Men's Weekly

.

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

  • Written by ACN Newswire - Press Releases

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

TOKYO, Sep 27, 2021 - (JCN Newswire) - AbbVie GK, Eisai Co., Ltd., and EA Pharma Co., Ltd announced today the additional approval for a high- dose regimen in adult patients with ulcerative colitis and for a new regimen in pediatric patients regarding fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA (generic name, adalimumab [recombinant];

Read more //?#

DesignStreet marks 27 years with a bold rebrand

In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...

Deputy partners with SuperAPI to streamline employee onboarding and help get shift-based industries ready for PayDay Super

Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...

KuCoin invests in Australian sponsorships of the ACC, plus a major campaign with golf icon Adam Scott

KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...

Australian companies pitching to the world’s wealthiest investors

#CapTech 2025 to bring world investors to Australia’s doorstep  One of Australia’s leading business and capital events is bringing together inves...

Small business backlash builds as RBA’s surcharge ban risks fuelling inflation

Australia’s small business sector has launched a fierce campaign against the Reserve Bank of Australia’s (RBA) proposed ban on debit and credit card...

Australia’s Young Entrepreneurs Redefining Success Through Legacy and Community Impact

A new generation of young Australian small business owners is redefining success, driven by a desire to create a lasting legacy through the positi...